Status:
COMPLETED
Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
Lead Sponsor:
Queensland Centre for Gynaecological Cancer
Collaborating Sponsors:
The University of Queensland
Royal Brisbane and Women's Hospital
Conditions:
Ovarian Cancer Stage III
Ovarian Cancer Stage IV
Eligibility:
FEMALE
18+ years
Brief Summary
This study will be the first prospective study enrolling consecutive patients with advanced ovarian cancer to determine the prevalence of thoracic and extra-abdominal involvement in this patient group...
Detailed Description
This study directly compares standard CT scanning with PET/CT scanning with gating (computer adjusted for breathing excursions) in patients with advanced EOC. The primary objective of this study is to...
Eligibility Criteria
Inclusion
- Female ≥18 years of age
- Suspected or histologically/cytologically proven Stage III or IV epithelial ovarian, fallopian tube, and primary peritoneal cancer
- Eastern Cooperative Oncology Group (ECOG) performance status ≤3
- Negative serum or urine pregnancy test in pre-menopausal women and women \< 2 years after the onset of menopause
- Signed written informed consent
Exclusion
- Estimated life expectancy of \<6 months
- Recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Laparotomy performed as component of staging/clinical management prior to gated PET/CT being performed.
- Unable to provide informed consent
Key Trial Info
Start Date :
February 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT02258165
Start Date
February 1 2015
End Date
December 1 2022
Last Update
April 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia, 4029
2
Mater Health Services
South Brisbane, Queensland, Australia, 4101